Business Context and Reporting Period
Creative Medical Technology Holdings, Inc. (CELZ) filed this Form 8-K on July 8, 2022, regarding a regulatory notice from The Nasdaq Stock Market. The Company is incorporated in Nevada and its common stock trades on The Nasdaq Stock Market LLC.
Key Financial Metrics
This filing does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on a listing compliance issue related to the Company's stock price.
Material Changes
The material event reported is the Company's failure to satisfy Nasdaq Listing Rule 5550(a)(2). The closing bid price of the Company's common stock fell below $1.00 per share for 30 consecutive business days. This non-compliance has no immediate impact on the Company's listing status.
Guidance, Outlook, and Risks
- Grace Period: The Company has a 180-day grace period ending January 4, 2023, to regain compliance.
- Compliance Requirement: To regain compliance, the bid price must close at $1.00 per share or more for a minimum of ten consecutive business days.
- Future Options: The Company may be eligible for an additional 180-day grace period if it meets Nasdaq's initial listing standards for The Nasdaq Capital Market (excluding the minimum bid price requirement).
- Management Action: Management intends to actively monitor the bid price and consider available options to regain compliance.
Investor Verification Checklist
- Verify the current trading price of CELZ to assess the likelihood of meeting the $1.00 threshold within the grace period.
- Monitor future filings for updates on the Company's plan to regain compliance or potential delisting notices.
- Review the Company's most recent 10-K or 10-Q for underlying financial health, as this 8-K does not contain financial statements.